✦ LIBER ✦

Synergistic immunomodulatory effects of interferon-β1b and the phosphodiesterase inhibitor pentoxifylline in patients with relapsing-remitting multiple sclerosis

✍ Scribed by Frank Weber; Thomas Polak; Astrid Günther; Boris Kubuschok; Julia Janovskaja; Andreas Bitsch; Sigrid Poser; Dr. Peter Rieckmann

Publisher: John Wiley and Sons
Year: 1998
Tongue: English
Weight: 1010 KB
Volume: 44
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.410440109

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Incidence of exacerbations in the first

Incidence of exacerbations in the first 90 days of treatment with recombinant human interferon β-1b in patients with relapsing-remitting multiple sclerosis

✍ Dr. Omar A. Khan; J. Richard Hebel 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 230 KB 👁 1 views

Magnetic resonance imaging results of th

Magnetic resonance imaging results of the PRISMS trial: A randomized, double-blind, placebo-controlled study of interferon-β1a in relapsing-remitting multiple sclerosis

✍ David K. B. Li; Donald W. Paty 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB 👁 2 views

The PRISMS (Prevention of Relapses and Disability by Interferon-␤1a Subcutaneously in Multiple Sclerosis) trial was a doubleblind, randomized, multicenter, phase III, placebo-controlled study of interferon-␤1a in 560 patients from 22 centers in 9 countries with clinically definite or laboratory-supp

New onset of rheumatoid arthritis during

New onset of rheumatoid arthritis during interferon β-1B treatment in a patient with multiple sclerosis: Comment on the case report by Jabaily and Thompson

✍ Saifeddin Alsalameh; Bernhard Manger; Peter Kern; Joachim Kalden 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 1 views